{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T18:24:04Z","timestamp":1751999044171,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"University of Bergen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10620-024-08369-x","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T13:02:21Z","timestamp":1709730141000},"page":"1336-1344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3398-3288","authenticated-orcid":false,"given":"Magdy","family":"El-Salhy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Gunnar","family":"Hatlebakk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"issue":"8","key":"8369_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","volume":"17","author":"CJ Black","year":"2020","unstructured":"Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17(8):473\u2013486.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"8","key":"8369_CR2","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3390\/nu11081824","volume":"11","author":"M El-Salhy","year":"2019","unstructured":"El-Salhy M, Hatlebakk JG, Hausken T. Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones. Nutrients. 2019;11(8):1824.","journal-title":"Nutrients."},{"issue":"11","key":"8369_CR3","doi-asserted-by":"publisher","first-page":"e14157","DOI":"10.1111\/nmo.14157","volume":"33","author":"M El-Salhy","year":"2021","unstructured":"El-Salhy M, Hausken T, Hatlebakk JG. Current status of fecal microbiota transplantation for irritable bowel syndrome. Neurogastroenterol Motil. 2021;33(11):e14157.","journal-title":"Neurogastroenterol Motil."},{"issue":"5","key":"8369_CR4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","volume":"69","author":"M El-Salhy","year":"2020","unstructured":"El-Salhy M, Hatlebakk JG, Gilja OH, et al. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020;69(5):859\u2013867.","journal-title":"Gut."},{"issue":"4","key":"8369_CR5","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1053\/j.gastro.2022.06.020","volume":"163","author":"M El-Salhy","year":"2022","unstructured":"El-Salhy M, Winkel R, Casen C, et al. Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at three years after transplantation. Gastroenterology. 2022;163(4):962\u2013994.e14.","journal-title":"Gastroenterology."},{"issue":"1","key":"8369_CR6","doi-asserted-by":"publisher","first-page":"e14200","DOI":"10.1111\/nmo.14200","volume":"34","author":"M El-Salhy","year":"2021","unstructured":"El-Salhy M, Kristoffersen AB, Valeur J, et al. Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2021;34(1):e14200.","journal-title":"Neurogastroenterol Motil."},{"issue":"2","key":"8369_CR7","first-page":"431","volume":"70","author":"M Camilleri","year":"2021","unstructured":"Camilleri M. FMT in IBS: a call for caution. Gut. 2021;70(2):431.","journal-title":"Gut."},{"issue":"21","key":"8369_CR8","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. N Engl J Med. 2019;381(21):2043\u20132050.","journal-title":"N Engl J Med."},{"issue":"21","key":"8369_CR9","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1056\/NEJMe1913807","volume":"381","author":"MJ Blaser","year":"2019","unstructured":"Blaser MJ. Fecal Microbiota Transplantation for Dysbiosis - Predictable Risks. N Engl J Med. 2019;381(21):2064\u20132066.","journal-title":"N Engl J Med."},{"issue":"1","key":"8369_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.gastro.2020.07.013","volume":"160","author":"T Holvoet","year":"2021","unstructured":"Holvoet T, Joossens M, V\u00e1zquez-Castellanos JF, et al. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial. Gastroenterology. 2021;160(1):145\u2013157.e8.","journal-title":"Gastroenterology."},{"issue":"9","key":"8369_CR11","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/00365521.2022.2064725","volume":"57","author":"M El-Salhy","year":"2022","unstructured":"El-Salhy M, Mazzawi T, Hausken T, et al. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms. Scand J Gastroenterol. 2022;57(9):1036\u20131045.","journal-title":"Scand J Gastroenterol."},{"key":"8369_CR12","doi-asserted-by":"crossref","unstructured":"El-Salhy M, Gilja OH, Hatlebakk JG. Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome. Neurogastroenterol Motil. 2023 Jul 10:e14641.","DOI":"10.1111\/nmo.14641"},{"key":"8369_CR13","doi-asserted-by":"crossref","unstructured":"Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017;66(4):569\u2013580.","DOI":"10.1136\/gutjnl-2016-313017"},{"issue":"2","key":"8369_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395\u2013402.","journal-title":"Aliment Pharmacol Ther."},{"issue":"5","key":"8369_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/MCP.0000000000000496","volume":"24","author":"C Hendriks","year":"2018","unstructured":"Hendriks C, Drent M, Elfferich M, et al. The Fatigue Assessment Scale: quality and availability in sarcoidosis and other diseases. Curr Opin Pulm Med. 2018;24(5):495\u2013503.","journal-title":"Curr Opin Pulm Med."},{"issue":"4","key":"8369_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1572-0241.2000.01941.x","volume":"95","author":"DA Drossman","year":"2000","unstructured":"Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000;95(4):999\u20131007.","journal-title":"Am J Gastroenterol."},{"issue":"5","key":"8369_CR17","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1053\/gast.2002.37095","volume":"123","author":"DA Drossman","year":"2002","unstructured":"Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123(5):2108\u20132131.","journal-title":"Gastroenterology."},{"issue":"1","key":"8369_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/apt.13236","volume":"42","author":"C Cas\u00e9n","year":"2015","unstructured":"Cas\u00e9n C, Veb\u00f8 HC, Sekelja M, et al. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther. 2015;42(1):71\u201383.","journal-title":"Aliment Pharmacol Ther."},{"issue":"4","key":"8369_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ajcn\/nqac217","volume":"116","author":"MSA Palmn\u00e4s-B\u00e9dard","year":"2022","unstructured":"Palmn\u00e4s-B\u00e9dard MSA, Costabile G, Vetrani C, et al. The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs. Am J Clin Nutr. 2022;116(4):862\u2013874.","journal-title":"Am J Clin Nutr."},{"issue":"8","key":"8369_CR20","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.3390\/nu12082175","volume":"12","author":"A Martinovi\u0107","year":"2020","unstructured":"Martinovi\u0107 A, Cocuzzi R, Arioli S, et al. Streptococcus thermophilus: To Survive, or Not to Survive the Gastrointestinal Tract, That Is the Question! Nutrients. 2020;12(8):2175.","journal-title":"Nutrients."},{"issue":"4","key":"8369_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/j.gastro.2020.09.003","volume":"160","author":"Q Li","year":"2021","unstructured":"Li Q, Hu W, Liu WX, et al. Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting \u03b2-Galactosidase. Gastroenterology. 2021;160(4):1179\u20131193.e14.","journal-title":"Gastroenterology."},{"issue":"3","key":"8369_CR22","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1128\/AEM.03133-13","volume":"80","author":"G Kaci","year":"2014","unstructured":"Kaci G, Goudercourt D, Dennin V, et al. Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract. Appl Environ Microbiol. 2014;80(3):928\u2013934.","journal-title":"Appl Environ Microbiol."},{"key":"8369_CR23","doi-asserted-by":"crossref","unstructured":"Rautio M, Eerola E, V\u00e4is\u00e4nen-Tunkelrott ML, et al. Reclassification of Bacteroides putredinis (Weinberg et al., 1937) in a new genus Alistipes gen. nov., as Alistipes putredinis comb. nov., and description of Alistipes finegoldii sp. nov., from human sources. Syst Appl Microbiol 2003;26(2):182\u2013188.","DOI":"10.1078\/072320203322346029"},{"issue":"3","key":"8369_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4056\/sigs.2956294","volume":"6","author":"AK Mishra","year":"2012","unstructured":"Mishra AK, Gimenez G, Lagier JC, et al. Genome sequence and description of Alistipes senegalensis sp. nov. Stand Genomic Sci. 2012;6(3):1\u201316.","journal-title":"Stand Genomic Sci."},{"issue":"1","key":"8369_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4056\/sigs.3527032","volume":"8","author":"K Mavromatis","year":"2013","unstructured":"Mavromatis K, Stackebrandt E, Munk C, et al. Complete genome sequence of the bile-resistant pigment-producing anaerobe Alistipes finegoldii type strain (AHN2437(T)). Stand Genomic Sci. 2013;8(1):26\u201336.","journal-title":"Stand Genomic Sci."},{"key":"8369_CR26","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3389\/fimmu.2020.00906","volume":"11","author":"BJ Parker","year":"2020","unstructured":"Parker BJ, Wearsch PA, Veloo ACM, et al. The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. Front Immunol. 2020;11:906.","journal-title":"Front Immunol."},{"issue":"1","key":"8369_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40168-019-0704-8","volume":"7","author":"K Oliphant","year":"2019","unstructured":"Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome. 2019;7(1):91.","journal-title":"Microbiome."},{"issue":"8","key":"8369_CR28","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1099\/ijsem.0.004342","volume":"70","author":"JS Liou","year":"2020","unstructured":"Liou JS, Huang CH, Ikeyama N, et al. Prevotella hominis sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2020;70(8):4767\u20134773.","journal-title":"Int J Syst Evol Microbiol."},{"issue":"1","key":"8369_CR29","doi-asserted-by":"publisher","first-page":"1922241","DOI":"10.1080\/19490976.2021.1922241","volume":"13","author":"JC Ezeji","year":"2021","unstructured":"Ezeji JC, Sarikonda DK, Hopperton A, et al. Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health. Gut Microbes. 2021;13(1):1922241.","journal-title":"Gut Microbes."},{"issue":"Pt 2","key":"8369_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1099\/ijs.0.64588-0","volume":"57","author":"M Sakamoto","year":"2007","unstructured":"Sakamoto M, Kitahara M, Benno Y. Parabacteroides johnsonii sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2007;57(Pt 2):293\u2013296.","journal-title":"Int J Syst Evol Microbiol."},{"key":"8369_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-230X-10-134","volume":"10","author":"SO Noor","year":"2010","unstructured":"Noor SO, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010;10:134.","journal-title":"BMC Gastroenterol."},{"issue":"8","key":"8369_CR32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/MCG.0000000000001281","volume":"54","author":"BK Perler","year":"2020","unstructured":"Perler BK, Chen B, Phelps E, et al. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection. J Clin Gastroenterol. 2020;54(8):701\u2013706.","journal-title":"J Clin Gastroenterol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08369-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08369-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08369-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T12:29:16Z","timestamp":1713443356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08369-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["8369"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08369-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"4 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Helse Fonna (grant no. 40415). Helse Vest (grant no. F-12854-D10636).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Grant support"}},{"value":"M.E.S and JGH have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}